Your browser doesn't support javascript.
loading
New evidence from plasma ceramides links apoE polymorphism to greater risk of coronary artery disease in Finnish adults.
Karjalainen, Juho-Pekka; Mononen, Nina; Hutri-Kähönen, Nina; Lehtimäki, Miikael; Hilvo, Mika; Kauhanen, Dimple; Juonala, Markus; Viikari, Jorma; Kähönen, Mika; Raitakari, Olli; Laaksonen, Reijo; Lehtimäki, Terho.
Afiliação
  • Karjalainen JP; Department of Clinical Chemistry, Fimlab Laboratories and Finnish Cardiovascular Research Center, Faculty of Medicine and Health Technology, Tampere University, Tampere, Finland. Electronic address: juhopekka.karjalainen@gmail.com.
  • Mononen N; Department of Clinical Chemistry, Fimlab Laboratories and Finnish Cardiovascular Research Center, Faculty of Medicine and Health Technology, Tampere University, Tampere, Finland.
  • Hutri-Kähönen N; Department of Paediatrics Tampere University Hospital and Faculty of Medicine and Health Technology, Tampere University, Tampere, Finland.
  • Lehtimäki M; Department of Clinical Chemistry, Fimlab Laboratories and Finnish Cardiovascular Research Center, Faculty of Medicine and Health Technology, Tampere University, Tampere, Finland.
  • Hilvo M; Zora Biosciences Oy Espoo, Finland.
  • Kauhanen D; Zora Biosciences Oy Espoo, Finland.
  • Juonala M; Department of Medicine, University of Turku, and Division of Medicine, Turku University Hospital, Turku, Finland; Murdoch Children's Research Institute Melbourne, Australia.
  • Viikari J; Zora Biosciences Oy Espoo, Finland.
  • Kähönen M; Department of Clinical Physiology Tampere University Hospital, and Finnish Cardiovascular Research Center, Faculty of Medicine and Health Technology, Tampere University, Tampere, Finland.
  • Raitakari O; Centre for Population Health Research University of Turku and Turku University Hospital, Department of Clinical Physiology and Nuclear Medicine, Turku University Hospital, and Research Centre of Applied and Preventive Cardiovascular Medicine, University of Turku, Turku, Finland.
  • Laaksonen R; Zora Biosciences Oy Espoo, Finland; Finnish Cardiovascular Research Center Faculty of Medicine and Health Technology, Tampere University and Finnish Clinical Biobank, Tampere University Hospital, Tampere, Finland.
  • Lehtimäki T; Department of Clinical Chemistry, Fimlab Laboratories and Finnish Cardiovascular Research Center, Faculty of Medicine and Health Technology, Tampere University, Tampere, Finland.
J Lipid Res ; 60(9): 1622-1629, 2019 09.
Article em En | MEDLINE | ID: mdl-31270131
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Apolipoproteínas E / Polimorfismo Genético / Doença da Artéria Coronariana / Ceramidas Tipo de estudo: Etiology_studies / Risk_factors_studies Limite: Humans País/Região como assunto: Europa Idioma: En Revista: J Lipid Res Ano de publicação: 2019 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Apolipoproteínas E / Polimorfismo Genético / Doença da Artéria Coronariana / Ceramidas Tipo de estudo: Etiology_studies / Risk_factors_studies Limite: Humans País/Região como assunto: Europa Idioma: En Revista: J Lipid Res Ano de publicação: 2019 Tipo de documento: Article